Macrolide resistance rates in respiratory pathogens in Slovenia following reduced macrolide use

International Journal of Antimicrobial Agents

Volumn 28, Issue 6, 2006, Pages 537-542

  Čižman, Milan ^a   Beović, Bojana ^a   Seme, Katja ^b   Paragi, Metka ^c   Štrumbelj, Iztok ^d   Müller Premru, Manica ^b   Čad Pečar, Silva ^c   Pokorn, Marko ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

^c NATIONAL INSTITUTE OF PUBLIC HEALTH   (Slovenia)

^d Regional Institute of Public Health   (Slovenia)

Author keywords

Antibiotic consumption; Antibiotic resistance; Macrolides

Indexed keywords

MACROLIDE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; HAEMOPHILUS INFLUENZAE; MORAXELLA CATARRHALIS; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SLOVENIA; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

ADOLESCENT; ADULT; AMBULATORY CARE; ANTI-BACTERIAL AGENTS; BACTERIA; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; HAEMOPHILUS INFLUENZAE; HUMANS; MACROLIDES; MORAXELLA (BRANHAMELLA) CATARRHALIS; PREVALENCE; RESPIRATORY TRACT INFECTIONS; SLOVENIA; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

EID: 33751261098     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2006.07.023     Document Type: Article

References (25)

1. European Surveillance of Antimicrobial Consumption. Results of the retrospective data collection. 1997-2001. In: 13th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID); 2003 May 10-13; Glasgow, UK (posters).
2. Goossens H, Ferech M, Vander Stichele R, Elseviers M; ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005;365:579-87.
3. Garcia-Rey C., Aguilar L., Baquero F., Casol J., and Martin E. Pharmaco-epidemiological analysis of principal differences between consumption of macrolides and rates of erythromycin resistance among Streptococcus pyogenes isolates in Spain. J Clin Microbiol 40 (2002) 3959-3963
4. Goossens H, Elseviers M, Ferech M, et al. Correlation between macrolide use and geographic diversity of erythromycin resistance among Streptococcus pneumoniae (SPN) and S. pyogenes (SPY) in 17 European countries. In: Programs and Abstracts of the 43rd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 2003 September 14-17; Chicago, IL. Washington, DC: American Society for Microbiology; 2003. p. 111 (abstract C2-67).
5. Pihlajamaki M., Kotlainen P., Kauila T., Klaukka T., Palva E., and Huovinen P. Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents. Clin Infect Dis 33 (2001) 4898
6. Granizo J.J., Aguilar L., Casal J., Garcia-Rey C., Dal Re R., and Baquero F. Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and β-lactam consumption in Spain (1979-1997). J Antimicrob Chemother 46 (2000) 767-773
7. Vanderkooi OG, Low DE, Green K, Powis JE, McGeer A; Toronto Invasive Bacterial Disease Network. Predicting antimicrobial resistance in invasive pneumococcal infections. Clin Infect Dis 2005;40:1288-97.
8. Reinert R.R., Al Lakham A., Lemperle M., et al. Emergence of macrolide and penicillin resistance among invasive pneumococcal isolates in Germany. J Antimicrob Chemother 49 (2002) 61-68
9. Barkai G., Greenberg D., Giron-Lasi N., Dreifuss E., Vardy D., and Dagan R. Community prescribing and resistant Streptococcus pneumoniae. Emerg Infect Dis 11 (2005) 829-837
10. Fujito K., Murono K., Yoshikawa M., and Murai T. Decline of erythromycin resistance of group A streptococci in Japan. Paediatr Infect Dis J 13 (1994) 1075-1078
11. Seppäla H., Klaukka T., Vupio-Varkulo J., et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med 337 (1997) 441-446
12. Kristinson KG, Hjalmarsdoltir MA, Gudnason KG. Continued decline in the incidence of penicillin nonsusceptible pneumococci in Iceland. In: Programs and Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 1998 September 24-27; San Diego, CA. Washington, DC: American Society for Microbiology; 1998 (abstract C22).
13. Čižman M., Srovin T., Pokorn M., Čad Pečar S., and Battelino S. Analysis of the causes and consequences of decreased antibiotic consumption over the last 5 years in Slovenia. J Antimicrob Chemother 55 (2005) 758-763
14. Statistical Office of the Republic of Slovenia. Population, 30 June 2005. Available at: http://www.stat.si/eng/tema_demografsko_prebivalstvo.asp (accessed 28 October 2005).
15. The Anatomical Therapeutic Chemical Classification System with Defined Daily Doses (ATC/DDD). Oslo, Norway: World Health Organization Centre for Drug Statistic Methodology; 2005.
16. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility testing. Approved Standard M2-A8. 8th ed. Wayne, PA: NCCLS; 2004.
17. Koneman E.W. Colour atlas and textbook of diagnostic microbiology. 3rd ed. (1988), JB Lippincott Company, Philadelphia, PA
18. Čižman M. The use and resistance to antibiotics in the community. Int J Antimicrob Agents 21 (2003) 297-307
19. Whitney C.G., Farley M.M., Hadler J., et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med 343 (2000) 1917-1924
20. Fenoll A., Jado I., Vicioso D., Perez A., and Casal J. Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Spain: update 1990 to 1996. J Clin Microbiol 36 (1998) 3447-3454
21. Davidson RJ, Chan CCK, Doern G, Zhanel G. Macrolide-resistant Streptococcus pneumoniae in Canada: correlation with azithromycin use. In: 13th European Congress of Clinical Microbiology and Infections Diseases (ECCMID); 2003 May 10-13; Glasgow, UK. Clin Microbiol Infect 2003;9(Suppl. 1):240.
22. Gin AS,Weshnoweski B, Laing N, Hoban DJ, Zhanel GG. Antibiotic-resistant S. pneumoniae and antibiotic use in Canada from 1998-2004. In: Programs and Abstracts of the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 2005 December 16-19; Washington, DC: American Society for Microbiology; 2005. p. 372 (abstract K-2089).
23. Paragi M, Kolman J, Kraigher A, Čižman M, Gubina M, Ribič F H; Slovenian Meningitis Study Group. Possibility of application of new pneumococcal conjugate vaccines in children in Slovenia. Vaccine 2003;21:4708-14.
24. Stephens D.S., Zughaier S.M., Whitney G., et al. Incidence of macrolide resistance in Streptococcus pneumoniae after introduction in the pneumococcal conjugate vaccine: population-based assessment. Lancet 365 (2005) 855-863
25. Kyaw M.H., Lymfield R., Schaffner W., et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 354 (2006) 1455-1463